0.00Open0.00Pre Close0 Volume0 Open Interest4.00Strike Price0.00Turnover72.83%IV-35.28%PremiumSep 20, 2024Expiry Date2.18Intrinsic Value100Multiplier27DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9893Delta0.0229Gamma2.81Leverage Ratio-0.0012Theta0.0029Rho2.78Eff Leverage0.0005Vega
LifeStance Health Stock Discussion
TQ2 '24: Net loss: $23.3m Revenue: $312.3m, up 20% YoY Clinician base: Up 14% to 6,984 Visit volumes: Up 15% to 2m Adj. EBITDA: $28.6m, up 103% YoY '24 guidance: Rev. $1.2b-$1.242b, Center Margin $363m-$383m, Adj. EBITDA $90m-$100m.
No comment yet